Sponsoring a test can help patients gain access to newer, more innovative and cutting-edge treatments while helping you more easily gain valuable insights into further development opportunities.
Helping patients find the right treatment
We are proud to build partnerships in order to increase access and improve patient outcomes.
We currently offer sponsored testing for ovarian cancer, non-small cell lung cancer (NSCLC) and systemic mastocytosis for patients that meet the eligibility requirements. We can help design and support initiatives across a broad range of therapeutic areas and indications.